Axon Enterprise (NASDAQ: AXON) printed its tenth consecutive quarter of revenue growth above 30% in the second quarter of fiscal 2026, with net sales of $904.4 million up 35.3% year over year, an annual recurring revenue of $1.6 billion up 38.5%, and future contracted bookings of $15.1 billion up 41.1%. The two stories inside the quarter pointed in opposite directions, and the report's verdict depends on which one is the load-bearing read. The first story is operational and unambiguous: adjusted EBITDA of $242.0 million was up 41% year over year on a 26.8% margin, the highest in company history for a quarter of this scale, and free cash flow swung from a $114.7 million outflow a year ago to roughly break-even in Q2 as the company lapped its conversion timing. The second story is earnings optical: GAAP net income fell 18.5% to $29.4 million and non-GAAP net income fell 13.0% to $155.5 million, with non-GAAP diluted earnings per share down 13.8% to $1.88, because the year-ago quarter carried a $75 million tax benefit that compressed the comparison base. Strip the calendar effect and the business accelerated.
The single bet underneath the entire report is the Axon Ecosystem thesis - that selling a TASER, a body camera, and an evidence-management subscription as separate products is being replaced by selling a connected public-safety network, with sensors feeding a cloud platform that runs AI workflows, dispatch, real-time operations, and records, and the network becoming more useful with each device, user, and workflow added. The Q2 numbers are the most concrete evidence yet that the bet is converting into a SaaS-shaped revenue line: 80% of customers now deploy at least one integrated hardware-software solution, more than 40% subscribe to a premium solution beyond the core TASER/body-camera/evidence stack, net revenue retention reached 126%, and software-and-services revenue grew 36% to $397.8 million with annual recurring revenue up 39%. The trade the market is making is whether a 35%-growing, 25.5%-margin business with a $15.1 billion forward-bookings backlog deserves a roughly 16x trailing enterprise-value-to-sales multiple at $50.6 billion of market value, and the answer the next six months will return depends on whether the company can convert bookings into revenue at the cadence the model assumes.